9amHealth, a diabetes management company, has raised USD 9.5 million in a Series A extension round. The funding round was led by The Cigna Group Ventures, with participation from 7Wire Ventures, Define Ventures, Leaps by Bayer, and Founders Fund. This round brings the total funds raised by the company to USD 29.2 million.
The new funds were allocated toward the company’s growth strategy and product development. It will facilitate expanding the company's existing solutions and internal team of specialists.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.